| Value | ₹468.8 Cr |
|---|
NSE filing, NSE: 5PAISA. Summary written from the filing by ALFA Finder's alert engine.
5Paisa Capital Ltd: key numbers
- Share price
- ₹339.00
- Market cap
- ₹1,589 Cr
- Revenue (annual)
- ₹319.6 Cr
- Net profit (annual)
- ₹44.18 Cr
- P/E (TTM)
- 38.0×Sector 19.7×
- Promoter holding
- 36.50%+0.00% QoQ
- FII holding
- 15.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from 5Paisa Capital Ltd
All →5Paisa Capital Debt & Borrowing: ₹25 Cr
5paisa Capital Limited has fully redeemed Commercial Papers amounting to ₹25 Crore upon maturity on October 09, 2026.
- Value
- ₹25.00 Cr
5Paisa Capital Capital Structure Change
5paisa Capital Limited has submitted updated shareholding disclosures as part of the regulatory process for its previously approved preferential issue of equity shares.
5Paisa Capital Board Meeting Date
5paisa Capital Ltd scheduled a board meeting for October 15, 2026, to consider and approve the standalone and consolidated financial results for the quarter ended September 30, 2026.
5Paisa Capital Other Announcement
5paisa Capital Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
5Paisa Capital Legal & Regulatory
5paisa Capital Limited received a Show Cause cum Demand Notice from GST authorities for Rs. 15.31 Crore, alleging excess Input Tax Credit availment.
- Value
- ₹15.31 Cr
- From
- Office of the Principal Commissioner of CGST & C. Excise, Mumbai East
5Paisa Capital Management Change
Mr. Ameya Agnihotri has resigned as Whole-Time Director and Chief Technology Officer of 5paisa Capital Limited, effective from the close of business on September 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.